Aurora Cannabis Inc (ACB)
5.6900
-0.3500 (-5.79%)
TSX · Last Trade: Apr 5th, 7:14 PM EDT
Detailed Quote
Previous Close | 6.040 |
---|---|
Open | 5.890 |
Bid | 5.700 |
Ask | 5.740 |
Day's Range | 5.460 - 5.900 |
52 Week Range | 4.950 - 12.85 |
Volume | 442,796 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 446,029 |
Chart
News & Press Releases
California’s legal marijuana production rose by 11.8% in 2024, reaching 1.4 million pounds, according to a newly released report by the state’s Department of Cannabis Control (DCC).
Via CannabisNewsWire · March 27, 2025
California’s legal marijuana production rose by 11.8% in 2024, reaching 1.4 million pounds, according to a newly released report by the state’s Department of Cannabis Control (DCC).
Via Investor Brand Network · March 27, 2025
Mariners Remain Stuck in a Cannabis Testing Gray Area
Testing for cannabis is making it increasingly harder for maritime companies to hire employees . Pre-employment drug tests have been a staple in the U.S. for several decades now but maritime employers say they are limiting the pool of eligible employees they can tap into.
Via CannabisNewsWire · March 14, 2025
Mariners Remain Stuck in a Cannabis Testing Gray Area
Testing for cannabis is making it increasingly harder for maritime companies to hire employees . Pre-employment drug tests have been a staple in the U.S. for several decades now but maritime employers say they are limiting the pool of eligible employees they can tap into.
Via Investor Brand Network · March 14, 2025
420 with CNW — Trump’s Cuts to Funding Put Marijuana Research at Risk
The federal government’s decision to reduce funding for research is jeopardizing 565 cannabis-related studies. In addition, a freeze on new grants from the National Institutes of Health (NIH) is slowing down future studies at a critical time, raising concerns about cannabis policy changes and potential consequences for the industry.
Via CannabisNewsWire · March 6, 2025
420 with CNW — Trump’s Cuts to Funding Put Marijuana Research at Risk
The federal government’s decision to reduce funding for research is jeopardizing 565 cannabis-related studies. In addition, a freeze on new grants from the National Institutes of Health (NIH) is slowing down future studies at a critical time, raising concerns about cannabis policy changes and potential consequences for the industry.
Via Investor Brand Network · March 6, 2025
420 with CNW — Ohio Residents Voice Their Opposition to GOP Efforts to Thwart Voter-Approved Marijuana Reforms
Several Ohio residents have voiced their opposition to a proposed measure that seeks to alter the state’s cannabis regulations. Senate Bill 56, introduced last month by Senator Steve Huffman, has received pushback, with 40 people submitting testimony against it during a Senate General Government Committee hearing.
Via CannabisNewsWire · February 25, 2025
420 with CNW — Ohio Residents Voice Their Opposition to GOP Efforts to Thwart Voter-Approved Marijuana Reforms
Several Ohio residents have voiced their opposition to a proposed measure that seeks to alter the state’s cannabis regulations. Senate Bill 56, introduced last month by Senator Steve Huffman, has received pushback, with 40 people submitting testimony against it during a Senate General Government Committee hearing.
Via Investor Brand Network · February 25, 2025
420 with CNW — Latest Poll Shows Most Texans Want Marijuana Legalized
A recent survey conducted by the University of Houston’s Hobby School of Public Affairs revealed that a significant number of Texans are in favor of legalizing cannabis for recreational use. The poll, which gathered responses from 1,200 adults across Texas and has a margin of error of 2.38%, found that over 60% of Texans support permitting recreational cannabis sales and consumption.
Via CannabisNewsWire · February 13, 2025
420 with CNW — Poll Finds Cannabis Helps Most People Cut Their Alcohol Intake
A recent survey reveals that over 50% of cannabis users reduce or completely stop their alcohol consumption after using marijuana. The poll, conducted by NuggMD, a marijuana telehealth platform, lends credence to the expanding theory of a substitution effect, according to which people are increasingly choosing marijuana because they believe it to be safer compared to alcohol.
Via CannabisNewsWire · February 3, 2025
420 with CNW — US Border Patrol Asks Court to Dismiss Businesses’ Lawsuit on Marijuana Seizures in New Mexico
The U.S. Customs and Border Protection (CBP) and Department of Homeland Security (DHS) are asking a federal judge to dismiss a case brought by New Mexico-licensed cannabis businesses. The businesses allege that the agencies unlawfully seized state-regulated cannabis products and arrested staff members at checkpoints within the state.
Via CannabisNewsWire · January 24, 2025
420 with CNW — Study Explores the Ethical Complexities Linked to Undertaking Marijuana Research Funded by Industry Actors
Researchers from the Center for Addiction and Mental Health (CAMH) are exploring the ethical implications of marijuana research that’s largely funded by actors with industry interests. Prior to the recent wave of state-level legalization, studying the potential risks and benefits of marijuana was practically impossible, making the recent rush of cannabis-related studies even more important for the fledgling cannabis market.
Via CannabisNewsWire · December 30, 2024
420 with CNW — Pennsylvania House Democrats Give Marijuana Legalization Another Go
Democrats in Pennsylvania are making another attempt to legalize cannabis through new legislation spearheaded by state Representatives Dan Frankel from Allegheny County and Rick Krajewski from Philadelphia. They are currently seeking co-sponsors for their proposal, marking the latest effort in a series of attempts over recent years to address cannabis legalization in the state.
Via CannabisNewsWire · December 16, 2024
Judge Halts Upcoming Minnesota Marijuana Business License Lottery
Last week, a judge in Ramsey County stopped a lottery that would’ve awarded marijuana licenses in Minnesota. This is a huge setback for regulators in the state, who are prepping for legal sales come 2025.
Via CannabisNewsWire · December 3, 2024

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), announced on Tuesday developments in cannabis science from Aurora's research and genetics facility, Aurora Coast."As a company committed to leading the way in terms of cannabis innovation, we are dedicated to putting patients first by harnessing the innovative solutions developed by our top researchers at Aurora Coast, our unique global research facility," Lana Culley, vice president of science and innovation at Aurora. "We strive to continuously raise the bar on product superiority and overall user experience so that we can deliver on our mission of providing patients with access to the very best medical cannabis."
Via Benzinga · November 26, 2024
420 with CNW — Australian Parliament to Vote on Cannabis Legalization This November
Australian legislators are preparing to vote on legislation that could pave the way for adult-use cannabis legalization across the nation. Senator David Shoebridge of the Greens Party, who has spearheaded the effort, announced on social media that the proposed bill is scheduled for a vote in Parliament on November 27.
Via CannabisNewsWire · November 22, 2024

Cannabis company Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) is launching the award-winning California-grown Claybourne brand in Canada, via an exclusive licensing agreement. Canadian medical cannabis company Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) revealed its latest lineup of innovations from Greybeard, San Rafael '71 and Tasty's brands for Canadian consumers.Cannabis producer and retailer The Cannabist Company (Cboe CA: CBST) (OTCQX: CBSTF) (FSE: 3LP) announced on Wednesday the launch of its partnership with Veda Warrior, a New Jersey-based minority woman-owned Ayurvedic wellness brand.
Via Benzinga · November 20, 2024
420 with CNW — Researcher Files Lawsuit to Block Marijuana Rescheduling Hearing
David Heldreth, CEO and founder of Panacea Plant Sciences, has filed a federal court lawsuit, claiming the DEA breached several legal protocols in preparing for a hearing on the Biden administration’s proposal to reclassify marijuana. The suit urges the court to issue an injunction halting the DEA’s scheduled hearing until these legal concerns are addressed.
Via CannabisNewsWire · November 14, 2024

Via Benzinga · November 6, 2024
420 with CNW — New Jersey Marijuana Advocates Discuss the Possibility of Increasing the Fee for Social Equity
Advocates in New Jersey are currently debating whether the state’s Marijuana Regulatory Commission should raise the fee directing revenue from recreational cannabis sales to fund social equity initiatives and support communities affected by past drug policies. The commission is set to meet soon to determine the fee rate that will apply starting January 1. Presently, the fee is set at $1.24 per ounce .
Via CannabisNewsWire · November 4, 2024
420 with CNW — Federally-Financed Studies Reveal Developmental Issues or Autism Aren’t Linked to Maternal Marijuana Use
Two new studies funded by the federal government may help reduce some concerns about cannabis use during pregnancy . One study found no link between early cannabis use in pregnancy and the development of autism in children, while the other showed no connection to an increased risk of developmental delays in early childhood.
Via CannabisNewsWire · October 24, 2024

Aurora Cannabis together with MedReleaf Australia, announced on Wednesday an enhanced product range of premium medical cannabis oil in Australia. The Canadian medical cannabis giant said the new cannabis oils include a variety of cannabinoid ratios to suit diverse patient needs and are now available for physicians to prescribe.The new products allow doctors to tailor treatments more precisely.
Via Benzinga · October 16, 2024
Research Explores How Adult-Use Legalization in Canada Affects Medical Marijuana
On Oct. 17, 2018, the Canadian government legalized the recreational use of marijuana. Given the legislation’s upcoming sixth anniversary, one researcher believes the time has come to assess how the process has impacted the medical marijuana market.
Via CannabisNewsWire · October 11, 2024

The U.S. Hemp Roundtable made headlines in early September as its board of directors welcomed two distinguished leaders from the hemp beverage sector to its officer ranks. New York's chief equity officer at the state Office of Cannabis Management, Damian Fagon, has formally resigned, effective November 27.
Via Benzinga · October 10, 2024
420 with CNW — Officials in Ukraine Approve Medical Marijuana Qualifying Conditions
The government of Ukraine recently approved a list of medical conditions that qualify for medical marijuana following the enactment of the country’s marijuana legislation by President Volodymyr Zelensky. The Ministry of Health shared a list of roughly 20 medical conditions eligible for marijuana treatment, noting that more conditions could be included later if medically approved.
Via CannabisNewsWire · October 7, 2024